Your browser doesn't support javascript.
loading
Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
Oteri, Avuwa Joseph; Adamu, Usman; Dieng, Boubacar; Bawa, Samuel; Terna, Nomhwange; Nsubuga, Peter; Owoaje, Eme T; Kassogue, Modibo; Jean Baptiste, Anne Eudes; Braka, Fiona; Shuaib, Faisal.
Afiliación
  • Oteri AJ; National Primary Health Care Development Agency, Abuja, Nigeria. Electronic address: joseph.oteri@nphcda.gov.ng.
  • Adamu U; National Primary Health Care Development Agency, Abuja, Nigeria.
  • Dieng B; Technical Assistance Consultant, Global Alliance for Vaccines and Immunisations, Nigeria.
  • Bawa S; World Health Organisation, Country Office, Abuja, Nigeria. Electronic address: bawasa@who.int.
  • Terna N; World Health Organisation, Country Office, Abuja, Nigeria. Electronic address: nomhwanget@who.int.
  • Nsubuga P; Global Public Health Solutions, Atlanta, GA, USA.
  • Owoaje ET; College of Medicine, University of Ibadan. Nigeria.
  • Kassogue M; United Nations Children's Fund, Country Office, Abuja, Nigeria.
  • Jean Baptiste AE; World Health Organisation, Country Office, Abuja, Nigeria.
  • Braka F; World Health Organisation, Country Office, Abuja, Nigeria.
  • Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria.
Vaccine ; 39 Suppl 3: C3-C11, 2021 11 17.
Article en En | MEDLINE | ID: mdl-33962837

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Poliomielitis / Sarampión Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Poliomielitis / Sarampión Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2021 Tipo del documento: Article